Juvenile idiopathic arthritis

Post on 07-May-2015

308 views 1 download

transcript

1

Juvenile Idiopathic Arthritis

2

Definition

• “Definite arthritis of unknown origin that begins before the age of 16 years and persists for at least 6 weeks”

Terminology• JRA/JCA/JIA

3

Juvenile Idiopathic Arthritis

• Most common chronic rheumatic disease of childhood.

• Group of related, genetically heterogeneous, phenotypically diverse immunoinflammatory disorders affecting joints and other structures.

• True frequency is not known 1 to 20 per 100,000 population.

4

Clinical Manifestations

• Swelling of a joint/synovial hypertrophy• Limited range of motion• Tenderness/Warmth/redness of a joint• Gait disturbance

• Fever, rash, serositis, red eyes• Anorexia, weight loss , and growth failure• Sleep disturbances, Fatigue

5

Systemic JIA

6

Polyarticular JIA

7

Radiograph of Hands

8

Oligoarticular JIA

9

Oligoarticular JIA - Radiograph of knees

10

Juvenile psoriatic arthritis

11

12

JIA Enthesitis related arthritis

13

JIA SubgroupsJIA subtype % Age Girls% Typical Pattern HLA B27

Systemic arthritis

4-7 4-7 48-70 Any or none 4-11

Oligoarthritis 46-54 4-5 66-78 Large joints, asymmetric 11-17

RF-negative polyarthritis

13-21 4-7 76-80 Any, often symmetric 10-11

RF-positive polyarthritis

1-4 11-12 83-92 typically symmetric arthritis 8-18

Psoriatic arthritis

3-7 8-10 57-69 Spine, lower extremities, distal interphalangealjoints

8-21

Enthesitis-related arthritis

4-14 10-12 9-38 Spine, sacroiliac, lower extremities, thoracic cagejoints

67-76

14

Prognosis

• Common misconception - “childhood arthritis would disappear in adulthood”

• Clinical remission in 40-60% (over 10 – 28 yrs) Systemic-onset JIA 0-50% Oligoarthritiscular JIA 50- 80% Polyarticular JIA 20-30% ERA 0- 30% PSA 30- 40%

15

ILAR(2001) criteria - juvenile idiopathic arthritis

1. Systemic2. Oligoarthritis

a. Persistentb. Extended

3. Polyarthritis (rheumatoid factor negative)4. Polyarthritis (rheumatoid factor positive)5. Psoriatic arthritis6. Enthesitis-related arthritis7. Undifferentiated arthritis

a. Fits no other categoryb. Fits more than one category

16

Complications

Growth retardation and osteopenia

17

TMJ involvement with growth failure of lower jaw

18

Sequelae of chronic uveitis

19

Other Complications

• Localised growth disturbances• Sexual maturation, sleep disturbance and

fatigue• Macrophage activation syndrome• Amylodosis• Drugs related side effects

20

Diagnosis

• History and clinical examination• Laboratory evaluation– Acute phase reactants– ANA/Rheumatoid factor– Fluid analysis

• Imaging– Radiographs– MRI/ CT/USG

21

Treatment - Drugs

• Steroids – intra-articular /oral• Non steroidal anti inflammatory drugs• DMARDS – Methotrexate, sulfasalazine,

leflunomide, cyclosporine,thalidomide• Biologicals – TNF alpha blockers, IL-1, IL-6

blockers, costimulation inhibitors ,Rituximab, IVIg.

22

Supportive care

• Physical therapy• Occupational therapy

• Psychological development and growth– Peer group relationship and schooling– Nutrition– Parent counselling

• Coordinated care– Pediatric rheumatologist– Opthalmology consultations

23

Surgical management

• Need for surgical therapy may be decreasing as a result of improved medical management

• Epiphysiodesis• ? Synovectomy• Soft tissue surgery• Arthroplasty

24

Take home messages

• JIA is more than just one disease• Arthritis is a clinical diagnosis• Early aggressive therapy according to subtype

of JIA (uveitis).• Bone health, physical and psychological

growth.

25

Thank you